Mirae Asset Global ETFs Holdings
HCAT icon

Mirae Asset Global ETFs Holdings’s Health Catalyst HCAT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,104
Closed -$40.8K – 3237
2026
Q1 		$40.8K Buy
32,104
+739
+2% +$1.39K ﹤0.01% 2949
2025
Q4 		$75K Sell
31,365
-370
-1% -$1.01K ﹤0.01% 2798
2025
Q3 		$90.4K Buy
+31,735
New +$109K ﹤0.01% 2711
2025
Q2 		– Sell
-36,047
Closed -$163K – 3097
2025
Q1 		$163K Buy
36,047
+2,624
+8% +$13.9K ﹤0.01% 2413
2024
Q4 		$236K Buy
33,423
+1,444
+5% +$11.5K ﹤0.01% 2303
2024
Q3 		$260K Buy
31,979
+2,693
+9% +$19.5K ﹤0.01% 2237
2024
Q2 		$187K Buy
+29,286
New +$188K ﹤0.01% 2289

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HCAT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 32,104 shares — an estimated $40.8K sold.

Mirae Asset Global ETFs Holdings first reported a position in HCAT in Q2 2024 and held it in 7 quarters. The position peaked at $260K in Q3 2024. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 32,104 Health Catalyst shares in Q2 2026, an estimated $40.8K.
  • Mirae Asset Global ETFs Holdings first reported a position in Health Catalyst in Q2 2024 and held it in 7 quarters.
  • Mirae Asset Global ETFs Holdings's Health Catalyst position peaked at $260K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.